+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopharmaceutical Excipients Market by Product (Binders, Coatings, Diluents), Source (Natural Excipients, Synthetic Excipients), Formulation Type, End User - Global Forecast 2025-2030- Product Image
Biopharmaceutical Excipients Market by Product (Binders, Coatings, Diluents), Source (Natural Excipients, Synthetic Excipients), Formulation Type, End User - Global Forecast 2025-2030- Product Image
Sale

Biopharmaceutical Excipients Market by Product (Binders, Coatings, Diluents), Source (Natural Excipients, Synthetic Excipients), Formulation Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337416
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

As the demand for advanced drug formulations intensifies, the biopharmaceutical excipients market is evolving rapidly, marked by innovation, shifting regulatory expectations, and supply chain diversification. Senior decision-makers face a dynamic landscape where strategic insight and timely action are crucial to remain competitive and compliant with industry requirements.

Market Snapshot: Biopharmaceutical Excipients Growth Trajectory

The biopharmaceutical excipients market grew from USD 3.61 billion in 2024 to USD 3.96 billion in 2025. It is expected to continue expanding at a CAGR of 9.69%, reaching USD 6.30 billion by 2030. This robust expansion reflects heightened demand for engineered excipients that deliver reliability, enhanced performance, and regulatory assurance, enabling medicine manufacturers to optimize the safety, stability, and delivery of new therapies across the globe.

Scope & Segmentation: Unpacking the Complexity of Biopharmaceutical Excipients

This report delivers comprehensive coverage across products, sourcing, end uses, and regions, addressing the full spectrum of market participants and emerging innovations. Key segmentation areas include:

  • Product Types: Includes binders (cellulosic binders, hydroxypropyl methylcellulose, povidone, starch & modified starches), coatings (controlled release, enteric, film, seal, sugar coatings), diluents (calcium phosphates, lactose, microcrystalline cellulose), disintegrants, lubricants & glidants, polyols (mannitol, sorbitol), preservatives, solubilizers & surfactants/emulsifiers (esters, polysorbates, triglycerides), and suspending & viscosity agents.
  • Source: Encompasses both natural excipients and synthetic excipients, balancing biocompatibility, process control, and sustainability.
  • Formulation Types: Covers injectable (intramuscular, intravenous, subcutaneous), oral (capsules, powders, tablets), and topical (creams, gels & ointments, lotions) formulations, meeting diverse delivery and performance needs.
  • End Users: Targets biopharmaceutical and pharmaceutical companies, contract manufacturers, and research institutes, each requiring tailored excipient solutions for clinical and commercial objectives.
  • Regional Coverage: Strategic insights span the Americas (including key U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (major Western and emerging markets), and Asia-Pacific (China, India, Japan, Australia, and more growth markets).
  • Technological Trends: Analyzes continuous manufacturing, advanced polymer synthesis, and digital quality systems reshaping excipient development and compliance.

Key Takeaways for Senior Decision-Makers

  • Excipients are shifting from traditional fillers to strategic enablers of advanced drug delivery, directly influencing therapy efficacy and product development timelines.
  • Growth is propelled by biologic therapies, personalized medicine, and demand for high-purity excipient grades, raising the bar for quality, traceability, and customization.
  • Regulatory dynamics are changing, with global harmonization juxtaposed against localized approval hurdles, prompting companies to refine both development and market entry strategies.
  • Supplier diversification and regional manufacturing hubs are emerging as risk mitigation responses to tariff challenges and complex international logistics.
  • Digital transformation underpins both process optimization and supply resilience, driving adoption of predictive analytics and end-to-end visibility across the supply chain.
  • Sustainability is gaining traction, with organizations prioritizing both synthetic and naturally derived excipients based on lifecycle impact and stakeholder expectations.

Tariff Impact: Navigating 2025 Trade Policy Shifts

The sector is contending with a new wave of tariffs in 2025, affecting essential supplies such as binders, polyols, and surfactants. These measures are prompting a realignment of procurement practices and a strategic turn toward supplier diversity and regional production. Enhanced inventory management and dynamic sourcing are now critical for sustained operational resilience.

Methodology & Data Sources

This research integrates primary interviews with industry leaders, procurement professionals, and regulatory authorities, supplemented by secondary analysis from regulatory filings, academic literature, and trade association reports. Data underwent rigorous cross-validation, and an expert panel reviewed draft findings for accuracy and relevance.

Why This Report Matters: Action-Oriented Insights for Executives

  • Enables informed investment and procurement decisions by offering clarity on functional excipient trends and evolving regulatory landscapes.
  • Empowers organizations to benchmark competitive strategies, identify risk mitigation actions, and prioritize innovation pipelines.
  • Facilitates alignment of cross-functional teams—R&D, quality assurance, and operations—for seamless scaling and compliance in an era of increasing complexity.

Conclusion: Strategic Imperatives for the Next Era

In this environment, leveraging robust analytics, fostering resilient supply chains, and staying ahead of regulatory changes remain vital. These imperatives will define successful leadership as biopharmaceutical excipients continue to underpin innovation in drug development and delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of digital twin technologies for predictive excipient performance optimization
5.2. Shift toward sustainable and biodegradable excipients in biopharmaceutical production
5.3. Increasing adoption of high-purity, animal-free excipients for next-gen biologics manufacturing
5.4. Rising demand for tailored excipient formulations in mRNA-based vaccine development
5.5. Regulatory harmonization efforts driving standardized excipient qualification globally
5.6. Growing collaborations between excipient suppliers and biotech firms for novel delivery systems
5.7. Scaling up cGMP manufacturing capabilities to meet surging biologic excipient requirements
5.8. Supply chain diversification strategies enhancing resilience in excipient sourcing post pandemic
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopharmaceutical Excipients Market, by Product
8.1. Introduction
8.2. Binders
8.2.1. Cellulosic Binders
8.2.2. Hydroxypropyl Methylcellulose (HPMC)
8.2.3. Povidone (Polyvinylpyrrolidone or PVP)
8.2.4. Starch & Modified Starches
8.3. Coatings
8.3.1. Controlled Release Coatings
8.3.2. Enteric Coatings
8.3.3. Film Coatings
8.3.4. Seal Coatings
8.3.5. Sugar Coatings
8.4. Diluents
8.4.1. Calcium Phosphates
8.4.2. Lactose
8.4.3. Microcrystalline Cellulose
8.5. Disintegrants
8.6. Lubricants & Glidants
8.7. Polyols
8.7.1. Mannitol
8.7.2. Sorbitol
8.8. Preservatives
8.9. Solubilizers & Surfactants/Emulsifiers
8.9.1. Esters
8.9.2. Polysorbates
8.9.3. Triglycerides
8.10. Suspending & Viscosity Agents
9. Biopharmaceutical Excipients Market, by Source
9.1. Introduction
9.2. Natural Excipients
9.3. Synthetic Excipients
10. Biopharmaceutical Excipients Market, by Formulation Type
10.1. Introduction
10.2. Injectable Formulations
10.2.1. Intramuscular
10.2.2. Intravenous
10.2.3. Subcutaneous
10.3. Oral Formulations
10.3.1. Capsules
10.3.2. Powders
10.3.3. Tablets
10.4. Topical Formulations
10.4.1. Creams
10.4.2. Gels & Ointments
10.4.3. Lotions
11. Biopharmaceutical Excipients Market, by End User
11.1. Introduction
11.2. Biopharmaceutical & Pharmaceutical Companies
11.3. Contract Manufacturers
11.4. Research Institutes
12. Americas Biopharmaceutical Excipients Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biopharmaceutical Excipients Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biopharmaceutical Excipients Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. ABITEC Corporation
15.3.2. Asahi Kasei Corporation
15.3.3. Actylis
15.3.4. Ashland Inc.
15.3.5. Avantor, Inc.
15.3.6. BASF SE
15.3.7. Clariant International Ltd.
15.3.8. Colorcon Ltd.
15.3.9. Croda International PLC
15.3.10. DFE Pharma GmbH & Co KG
15.3.11. Eastman Chemical Company
15.3.12. Evonik Industries AG
15.3.13. Fuji Chemical Industries Co., Ltd.
15.3.14. IMCD N.V.
15.3.15. Innophos Holdings, Inc.
15.3.16. International Flavors & Fragrances Inc.
15.3.17. JRS PHARMA GmbH + Co. KG
15.3.18. Kerry Group PLC
15.3.19. Meggle Group GmbH
15.3.20. Merck KGaA
15.3.21. Mitsubishi Chemical Group Corporation
15.3.22. NOF Corporation
15.3.23. Novo Nordisk A/S
15.3.24. Pfanstiehl, Inc.
15.3.25. Roquette Frères S.A.
15.3.26. Shin-Etsu Chemical Co., Ltd.
15.3.27. Sigachi Industries Limited
15.3.28. Spectrum Laboratory Products, Inc.
15.3.29. SPI Pharma, Inc. By Associated British Foods
15.3.30. The Archer-Daniels-Midland Company
15.3.31. The Dow Chemical Company
15.3.32. The Lubrizol Corporation
15.3.33. Wacker Chemie AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIOPHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIOPHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIOPHARMACEUTICAL EXCIPIENTS MARKET: RESEARCHAI
FIGURE 24. BIOPHARMACEUTICAL EXCIPIENTS MARKET: RESEARCHSTATISTICS
FIGURE 25. BIOPHARMACEUTICAL EXCIPIENTS MARKET: RESEARCHCONTACTS
FIGURE 26. BIOPHARMACEUTICAL EXCIPIENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 171. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 172. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 173. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
TABLE 174. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2030 (USD MILLION)
TABLE 175. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
TABLE 176. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2030 (USD MILLION)
TABLE 177. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
TABLE 178. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2030 (USD MILLION)
TABLE 179. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
TABLE 180. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2030 (USD MILLION)
TABLE 181. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
TABLE 182. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2030 (USD MILLION)
TABLE 183. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 184. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 185. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 186. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 187. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 188. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 189. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 190. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 191. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 192. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 193. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 196. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 197. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 210. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 211. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM BIOPHARMACEUTICAL EXCIPIE

Samples

Loading
LOADING...

Companies Mentioned

  • ABITEC Corporation
  • Asahi Kasei Corporation
  • Actylis
  • Ashland Inc.
  • Avantor, Inc.
  • BASF SE
  • Clariant International Ltd.
  • Colorcon Ltd.
  • Croda International PLC
  • DFE Pharma GmbH & Co KG
  • Eastman Chemical Company
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • IMCD N.V.
  • Innophos Holdings, Inc.
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group PLC
  • Meggle Group GmbH
  • Merck KGaA
  • Mitsubishi Chemical Group Corporation
  • NOF Corporation
  • Novo Nordisk A/S
  • Pfanstiehl, Inc.
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • Sigachi Industries Limited
  • Spectrum Laboratory Products, Inc.
  • SPI Pharma, Inc. By Associated British Foods
  • The Archer-Daniels-Midland Company
  • The Dow Chemical Company
  • The Lubrizol Corporation
  • Wacker Chemie AG

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.96 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.3 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned33

Related Topics

Related Reports

Biopharmaceutical Excipients Market - Focused Insights 2024-2029 - Product Image

Biopharmaceutical Excipients Market - Focused Insights 2024-2029

  • Report
  • 163 Pages
  • Global
From
Lipid-Based Pharma Excipients Market - Global Outlook & Forecast 2025-2030 - Product Image

Lipid-Based Pharma Excipients Market - Global Outlook & Forecast 2025-2030

  • Report
  • 432 Pages
  • Global
From
Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function, End-User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function, End-User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Lipid-Based Pharma Excipients Market by Product Type, Source of Lipid, Application, Functionality, End-User - Global Forecast to 2030 - Product Image

Lipid-Based Pharma Excipients Market by Product Type, Source of Lipid, Application, Functionality, End-User - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Specialty Biopharmaceutical Excipient Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Specialty Biopharmaceutical Excipient Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Market

The biopharmaceutical excipient market is a subset of the drug discovery industry, which focuses on the development of new drugs and therapies. Excipients are inactive ingredients used to formulate drugs, and are essential for the production of safe and effective medicines. They are used to improve the stability, solubility, and bioavailability of active pharmaceutical ingredients. Excipients also help to protect the drug from environmental factors, such as light and moisture. The biopharmaceutical excipient market is driven by the increasing demand for biopharmaceuticals, as well as the need for improved drug delivery systems. The market is also driven by the growing demand for cost-effective and safe drug formulations. Some of the major companies in the biopharmaceutical excipient market include BASF, Evonik Industries, Ashland, Croda International, and Lubrizol Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.